Prevalence and risk factors of advanced colorectal neoplasms in asymptomatic Korean people between 40 and 49 years of age

Journal of Gastroenterology and Hepatology (Australia)

Volumn 32, Issue 1, 2017, Pages 98-105

  Koo, Ja Eun ^a   Kim, Kyung Jo ^a   Park, Hye Won ^a   Kim, Hong Kyu ^a   Choe, Jae Won ^a   Chang, Hye Sook ^a   Lee, Ji Young ^a   Myung, Seung Jae ^a   Yang, Suk Kyun ^a   Kim, Jin Ho ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

colorectal adenoma; metabolic syndrome; risk factor; young adults

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ADENOMATOUS POLYP; ADULT; ADVANCED CANCER; ARTICLE; ASYMPTOMATIC DISEASE; CANCER RISK; CANCER SCREENING; COLON CANCER; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; FEMALE; GROUPS BY AGE; HUMAN; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; RECTUM ADENOMA; RISK FACTOR; SMOKING; AGE DISTRIBUTION; ASIAN CONTINENTAL ANCESTRY GROUP; COLONY COLLAPSE; COLORECTAL NEOPLASMS; MASS SCREENING; SOUTH KOREA;

ADULT; AGE DISTRIBUTION; ASIAN CONTINENTAL ANCESTRY GROUP; COLONY COLLAPSE; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; REPUBLIC OF KOREA; RISK FACTORS; SMOKING;

EID: 85008477764     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.13454     Document Type: Article

References (32)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin. 2011; 61: 69–90.
2. Levin B, Lieberman DA, McFarland B et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570–1595.
3. Nishihara R, Wu K, Lochhead P et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N. Engl. J. Med. 2013; 369: 1095–1105.
4. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann. Intern. Med. 2009; 150: 1–8.
5. Zauber AG, Winawer SJ, O'Brien MJ et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N. Engl. J. Med. 2012; 366: 687–696.
6. Siegel RL, Jemal A, Ward EM. Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol. Biomarkers Prev. 2009; 18: 1695–1698.
7. Davis DM, Marcet JE, Frattini JC, Prather AD, Mateka JJ, Nfonsam VN. Is it time to lower the recommended screening age for colorectal cancer? J. Am. Coll. Surg. 2011; 213: 352-361.
8. O'Connell JB, Maggard MA, Liu JH, Etzioni DA, Livingston EH, Ko CY. Rates of colon and rectal cancers are increasing in young adults. Am. Surg. 2003; 69: 866–872.
9. You YN, Xing Y, Feig BW, Chang GJ, Cormier JN. Young-onset colorectal cancer: is it time to pay attention? Arch. Intern. Med. 2012; 172: 287–289. DOI: 10.1001/archinternmed.2011.602 Epub 2011 Dec 12.
10. Rex DK, Petrini JL, Baron TH et al. Quality indicators for colonoscopy. Gastrointest. Endosc. 2006; 63: S16–S28.
11. Vakil N. Measurement of lesions by endoscopy: an overview. Endoscopy 1995; 27: 694–697.
12. Hamilton SR, Aaltonen LA. World Health Organization Classification of Tumors. In: Pathology and Genetics of Tumors of the Diagestive System, Vol. 103. Lyon: France: IARC Press, 2000; 883–893.
13. Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012; 143: 844–857.
14. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N. Engl. J. Med. 2000; 343: 162–168.
15. Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J. Gastroenterol. 2003; 38: 954–961.
16. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735–2752.
17. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Results of screening colonoscopy among persons 40 to 49 years of age. N. Engl. J. Med. 2002; 346: 1781–1785.
18. Rundle AG, Lebwohl B, Vogel R, Levine S, Neugut AI. Colonoscopic screening in average-risk individuals ages 40 to 49 vs 50 to 59 years. Gastroenterology 2008; 134: 1311–1315.
19. Chung SJ, Kim YS, Yang SY et al. Prevalence and risk of colorectal adenoma in asymptomatic Koreans aged 40–49 years undergoing screening colonoscopy. J. Gastroenterol. Hepatol. 2010; 25: 519–525.
20. Thoma MN, Castro F, Golawala M, Chen R. Detection of colorectal neoplasia by colonoscopy in average-risk patients age 40–49 versus 50–59 years. Dig. Dis. Sci. 2011; 56: 1503–1508.
21. Choe JW, Chang HS, Yang SK et al. Screening colonoscopy in asymptomatic average-risk Koreans: analysis in relation to age and sex. J. Gastroenterol. Hepatol. 2007; 22: 1003–1008.
22. Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999–2006. Diabetes Care 2011; 34: 216–219.
23. Lim S, Shin H, Song JH et al. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998–2007. Diabetes Care 2011; 34: 1323–1328.
24. Esposito K, Chiodini P, Capuano A et al. Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis. Endocrine 2013; 44: 634–647.
25. Kim BC, Shin A, Hong CW et al. Association of colorectal adenoma with components of metabolic syndrome. Cancer Causes Control 2012; 23: 727–735.
26. Kim JH, Lim YJ, Kim YH et al. Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol. Biomarkers Prev. 2007; 16: 1543–1546.
27. Lee GE, Park HS, Yun KE et al. Association between BMI and metabolic syndrome and adenomatous colonic polyps in Korean men. Obesity (Silver Spring) 2008; 16: 1434–1439.
28. Jinjuvadia R, Patel S, Liangpunsakul S. The association between metabolic syndrome and hepatocellular carcinoma: systemic review and meta-analysis. J. Clin. Gastroenterol. 2014; 48: 172–177.
29. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992; 15: 318–368.
30. Wu Y, Yakar S, Zhao L, Hennighausen L, LeRoith D. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res. 2002; 62: 1030–1035.
31. Chao A, Connell CJ, Cokkinides V, Jacobs EJ, Calle EE, Thun MJ. Underuse of screening sigmoidoscopy and colonoscopy in a large cohort of US adults. Am. J. Public Health 2004; 94: 1775–1781.
32. Butterly LF, Goodrich M, Onega T et al. Improving the quality of colorectal cancer screening: assessment of familial risk. Dig. Dis. Sci. 2010; 55: 754–760.